Tom Brieva

Tom Brieva is an experienced professional in the field of biotechnology, currently serving as Vice President and Head of Technical Development at Legend Biotech. Previously, Tom held the position of Vice President of Cell Therapy Process, Analytical, and Technology Development at Resilience. Prior to that, Tom was Vice President of Process Development at Tmunity Therapeutics Incorporated. Tom's expertise in cell therapy was further demonstrated during tenure as Senior Director of Cell Therapy Process Development at Bristol-Myers Squibb following its acquisition of Celgene.